News & Publications

On May 9, 2017, Dermatology News published an article discussing the importance in conducting surveillance for recurrence in Merkel cell carcinoma. A two year retrospective cohort study conducted by Ms. Aubriana McEvoy and other colleagues, under the guidance of Dr. Paul Nghiem, has laid the foundat...

The 13th Congress of the European Association of Dermato-Oncology (EADO) was held in Athens, Greece on May 3-6, 2017 at the Megaron Athens International Conference Center. The event highlighted some of the major aspects of Merkel cell carcinoma, melanoma, and various other skin cancers. Dr. Nghiem ...

American Academy of Dermatology Annual Meeting Orlando, FL Prepared by Drs. Song Park, Paul Nghiem and Hannah Thomas  Announcements: If you are interested in presenting at next year’s MMIG meeting in San Diego, California on Friday February 16th, 2018 (5 – 7 pm), please send Paul...

A team in France has developed a similar test for antibodies to the Merkel virus oncoprotein. Information about getting the test performed in Europe can be found HERE. 

On April 6, 2017, the SCCA published an article on the newly FDA approved treatment for Merkel cell carcinoma. “While skin cancer is one of the most common cancers, patients with a rare form called Merkel cell carcinoma have not had an approved treatment option until now,” said Dr. Richard Pazd...

Until recently, patients with the rare skin cancer Merkel cell carcinoma could expect to live just months after it started spreading and became resistant to chemotherapy. But, less than two weeks ago, everything changed. And today things are looking even better. On March 23, the immunotherapy drug a...

For as long as I can remember, I have been captivated by the idea of belonging to a dynamic team that explores a frontier relevant to humanity. Some of my earliest childhood memories were of being transfixed by NASA’s Apollo missions to the moon. Like many of my friends, I dreamed of becoming an a...

Our Merkel cell carcinoma patient handout was updated on December 29, 2016, and can be found here. This handout is a culmination of the latest information in the background and treatment of Merkel cell carcinoma from scientific literature and the Nghiem Lab’s research. The handout is meant to prov...

Dear friends of Merkel cell carcinoma research, During this time of giving and celebrations, I want to let you know how appreciative our Merkel Team is of your support.  This year was one of many exciting milestones that I am excited to share with you.  We have created the new website that you ...

On December 7, 2016, GeekWire published an article highlighting the various advantages of the Merkel cell carcinoma antibody test.  The test can be used to detect recurrence of MCC (in patients that produce antibodies) prior to catching a recurrence on a scan.  Dr. Nghiem, the lead author of the ...